Abstract: The present application discloses stilbene derivative compounds and phenyl-benzofuran compositions, useful in the manufacture of dye-sensitized solar cells and other similar technology.
Abstract: The present application discloses stilbene derivative compounds and phenylbenzofuran compositions, useful in the manufacture of dye-sensitized solar cells and other similar technology.
Abstract: Provided herein are improvements to dye-sensitized photovoltaic cells that enhance the ability of those cells to operate in normal room lighting conditions. These improvements include printable, non-corrosive, nonporous hole blocking layer formulations that improve the performance of dye-sensitized photovoltaic cells under 1 sun and indoor light irradiation conditions. Also provided herein are highly stable electrolyte formulations for use in dye-sensitized photovoltaic cells. These electrolytes use high boiling solvents, and provide unexpectedly superior results compared to prior art acetonitrile-based electrolytes. Also provided herein are chemically polymerizable formulations for depositing thin composite catalytic layers for redox electrolyte-based dye-sensitized photovoltaic cells. The formulations allow R2R printing (involves coating, fast chemical polymerization, rinsing of catalytic materials with methanol) composite catalyst layers on the cathode.
Abstract: The present application discloses compounds and compositions, useful in the manufacture of dye-sensitized solar cells and other similar technology.
Type:
Application
Filed:
March 25, 2022
Publication date:
July 28, 2022
Applicant:
AMBIENT PHOTONICS, INC.
Inventors:
Kethinni Chittibabu, John C. Warner, Debora Martino, Rich Allen, Sammaiah Thota
Abstract: The present application discloses stilbene derivative compounds and compositions, and methods for treating ocular diseases, neurological disorders and protein aggregation-related disorders in patients using the compounds and compositions as disclosed herein.
Abstract: The present application discloses compounds and compositions, useful in the manufacture of dye-sensitized solar cells and other similar technology.
Type:
Grant
Filed:
August 26, 2020
Date of Patent:
March 29, 2022
Assignee:
AMBIENT PHOTONICS, INC.
Inventors:
Kethinni Chittibabu, John C. Warner, Debora Martino, Rich Allen, Sammaiah Thota
Abstract: The present application discloses stilbene derivative compounds and compositions, and methods for treating ocular diseases, neurological disorders and protein aggregation-related disorders in patients using the compounds and compositions as disclosed herein.
Abstract: The present application discloses stilbene derivative compounds and phenyl-benzofuran compositions, useful in the manufacture of dye-sensitized solar cells and other similar technology.
Abstract: The present application discloses compounds and compositions, useful in the manufacture of dye-sensitized solar cells and other similar technology.
Type:
Application
Filed:
August 26, 2020
Publication date:
December 17, 2020
Applicant:
AMBIENT PHOTONICS, INC.
Inventors:
Kethinni Chittibabu, John C. Warner, Debora Martino, Rich Allen
Abstract: Provided herein are improvements to dye-sensitized photovoltaic cells that enhance the ability of those cells to operate in normal room lighting conditions. These improvements include printable, non-corrosive, nonporous hole blocking layer formulations that improve the performance of dye-sensitized photovoltaic cells under 1 sun and indoor light irradiation conditions. Also provided herein are highly stable electrolyte formulations for use in dye-sensitized photovoltaic cells. These electrolytes use high boiling solvents, and provide unexpectedly superior results compared to prior art acetonitrile-based electrolytes. Also provided herein are chemically polymerizable formulations for depositing thin composite catalytic layers for redox electrolyte-based dye-sensitized photovoltaic cells. The formulations allow R2R printing (involves coating, fast chemical polymerization, rinsing of catalytic materials with methanol) composite catalyst layers on the cathode.
Abstract: The present application discloses 2-phenyl benzofuran derivative compounds and compositions, and methods for treating ocular diseases, neurological disorders and protein aggregation-related disorders in patients using the compounds and compositions as disclosed herein.
Type:
Grant
Filed:
November 10, 2016
Date of Patent:
March 17, 2020
Assignee:
AMBIENT PHOTONICS, INC.
Inventors:
John C. Warner, Srinivasa R. Cheruku, Jeffery A. Gladding